Aoxin Q&M Dental Group Ltd.

Aoxin Q&M Dental Group Ltd.

SSGX:1D4
0.16
SGD
-0.01
(-4.29%)
283.48MMarket Cap
Aoxin Q&M Dental Group Ltd.
SGX:1D4
(Singapore Exchange)

Recent

price

0.16

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
- -
0.06
0.11
0.21
0.26
0.27
0.32
0.3
0.34
0.23
0.3
0.35
0.32
- -
Revenue per Share
-0.01
0.01
0.02
0.02
0.01
- -
-0.03
-0.03
-0.02
-0.11
-0.08
-0.02
0.01
- -
Basic EPS, GAAP
-0.01
0.01
0.02
0.01
0.02
-0.08
-0.01
0.02
-0.01
0.02
0.02
0.05
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
0.01
- -
0.01
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.01
0.01
0.04
0.19
0.54
0.55
0.53
0.5
0.61
0.52
0.45
0.43
0.34
0.39
Book Value per Share
-0.02
-0.2
-0.17
-0.05
0.28
0.29
0.23
0.21
0.39
0.3
0.23
0.22
0.22
0.28
Tangible Book Value per Share
434
434
434
415
381
443
445
445
470
596
597
511
535
800
Basic Weighted Avg Shares
- -
25
46
87
101
119
141
133
160
140
177
177
171
- -
Sales/Revenue/Turnover
-888.72
13.13
18.86
20.85
11.1
0.76
-4.76
-3.99
-4.63
-8.91
2.66
4.72
5.67
- -
Operating Margin (%)
- -
2
4
5
6
8
18
18
18
18
18
15
15
- -
Depreciation Expense
-4
4
10
9
5
- -
-14
-12
-7
-68
-47
-8
7
- -
Net Income, GAAP
- -
55.56
45.11
43.87
42.5
213.53
- -
- -
- -
- -
- -
- -
17.41
- -
Effective Tax Rate (%)
-878.96
14.67
20.75
10.73
4.98
-0.38
-9.58
-9.13
-4.57
-48.43
-26.68
-4.51
4.08
- -
Profit Margin (%)
-6
-58
-34
-41
86
69
27
44
61
51
70
83
183
260
Working Capital
- -
- -
- -
- -
- -
- -
38
33
28
23
18
11
7
7
LT Debt
-5
61
88
95
237
246
234
223
364
311
267
259
349
453
Total Equity
- -
5.94
6.35
10.98
3.86
-0.42
- -
- -
- -
- -
- -
- -
2.27
- -
Return on Invested Capital (%)
- -
-16.06
-7.53
1.39
3.03
-0.19
- -
- -
- -
- -
- -
- -
2.45
- -
Return on Capital (%)
- -
- -
84.04
19.28
3.17
-0.19
-5.63
-5.29
-2.5
-20.07
-16.38
-3.04
2.3
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
6
5
3
LT Borrowings
- -
- -
- -
LT Finance Leases
9
7
7
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
597
1,023
1,157
Market Capitalization
127
935
1,487

Working Capital

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
122
209
286
Cash, Cash Equivalents & STI
67
149
223
Accounts Receivable, Net
42
41
50
Inventories
12
10
10
Total Current Liabilities
30
27
25
Payables & Accruals
- -
- -
- -
ST Debt
6
5
3
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
21.82%
13.23%
35.03%
Free Cash Flow
-135.5%
-89.96%
-93.11%
Net Income, GAAP
319.87%
96.78%
-187.18%
Sales/Revenue/Turnover
16.5%
6.28%
-3.63%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
177
2025
- -
- -
171
2026
- -
- -
- -

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.02
2025
- -
- -
0.01
2026
- -
- -
- -

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Business
Aoxin Q&M Dental Group Limited is an investment holding company and a leading provider of private dental healthcare services, dental laboratory services, and dental equipment and consumables distribution in the People's Republic of China. Founded in 1997 and headquartered in Shenyang, Liaoning Province, China, the company operates primarily in northern China and functions as a subsidiary of Singapore-based Q & M Dental Group (Singapore) Limited. The company structures its operations into three core business segments: Primary Dental Services, Dental Laboratory Services, and Distribution of Dental Equipment and Supplies. Through its Primary Dental Services segment, the company operates a network of dental hospitals and polyclinics delivering general and specialized dental care, including general dentistry such as scaling, fillings, root canal therapy, and tooth extractions; restorative treatments and prosthodontics; dental implantology and oral and maxillofacial surgeries; orthodontics and malocclusion correction utilizing traditional fixed appliances and clear aligner therapies; cosmetic and aesthetic dentistry, including composite veneers and teeth whitening; and specialized paediatric dental services. Through its Dental Laboratory Services segment, the company designs, fabricates, and sells customized dental prostheses and appliances, including porcelain-fused-to-metal and all-ceramic crowns; zirconia bridges; full and partial removable dentures; orthodontic retainers; and computer-aided design and manufacturing (CAD/CAM) surgical guides. Through its Distribution of Dental Equipment and Supplies segment, the company distributes medical and dental devices, clinical instruments, diagnostic imaging equipment, and dental consumable supplies to third-party hospitals, dental polyclinics, and private practitioners. In recent developments, Aoxin Q&M Dental Group has accelerated the digitalization of its dental healthcare operations and laboratory manufacturing pipelines, deploying digital intraoral scanning systems, 3D printing technologies, and automated CAD/CAM milling infrastructure across its network to enhance diagnostic accuracy and shorten prosthetic fabrication cycles. The company has completed post-pandemic operational realignments by refocusing corporate resources on core clinical dentistry and expanding dedicated paediatric and orthodontic treatment suites within its flagship hospitals. In addition, the group has deepened supply chain synergies with parent company Q & M Dental Group (Singapore) Limited to optimize equipment procurement costs and expanded the service capacity of its established clinics across Tier-2 and Tier-3 urban markets in Liaoning Province.